180 Life Sciences and University of Oxford Announce Publication of Positive Phase 2b Dupuytren s Disease Study Results in The Lancet Rheumatology · . | May 2, 2022
180 Life Sciences and University of Oxford Announce Publication of Positive Phase 2b Dupuytren’s Disease Study Results in The Lancet Rheumatology - read this article along with other careers information, tips and advice on BioSpace
The study achieved the primary endpoint of reduction in nodule hardness at 12 months and secondary endpoint of reduction in nodule size at multiple time.
180 Life Sciences and University of Oxford Announce Publication of Positive Phase 2b Dupuytren s Disease Study Results in The Lancet Rheumatology streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
180 Life Sciences and University of Oxford Announce Publication of Positive Phase 2b Dupuytren s Disease Study Results in The Lancet Rheumatology streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.